Tag: CPXX

Blue Horseshoe Stocks: CLTX Recap & More

Celsus Therapeutics Plc. CLTX

The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR

Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.

That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.

We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.

Callaway Golf Co. ELY

ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.

The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.

CARLSBAD, Calif., July 14, 2015 /PRNewswire/ — Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR

EnteroMedics, Inc.  ETRM

Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.

We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions.  There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.

Extended Watchlist:
BIOC, CLSN, TBIO, CEL, VLTC, CPXX

Blue Horseshoe Stocks: TPIV Recap, PZOO News & More

TapImmune, Inc. TPIV

Despite already being on one heck of a run, as we were stating in yesterday’s morning report, TPIV ended up having another landmark session in which it would surge to its highest PPS in almost a year.

The stock posted an early low of 1.20 before breaking out to 1.71, which registered as an intraday spike of 43% and occurred on heavy volume. TPIV also took the title of most actively-traded stock on the OTC for yesterday’s session, with shares changing hands 3,388 times.

We want to congratulate anyone who’s been tracking TPIV along with us recently; the total increase we’ve now observed in just eight sessions is equal to 137% (.72-1.71).

Yesterday’s continued uptrend was aided by the following PR:
TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients (Tue, Jun 23)

Pazoo, Inc. PZOO

Those of our subscribers that have joined our ranks in the past few weeks will need a little bringing up to speed on PZOO. We introduced this play at the beginning of April, and tracked it over an epic run from .0049 to .0204, which amounted to a 316% swing.

It has been nearly four weeks since we touched base with this play, and with a fresh PR released this morning, we think now would be a good time  to take another look. The stock has done well maintaining support throughout the month of June, trading in a channel between .009 to .011, holding a good bit of the advances we witnessed earlier in the Spring.

The storyline we’ve been following on PZOO of its 40% ownership in MA & associates, a Nevada-based marijuana testing agency, just got a whole lot more interesting with PZOO officially announcing that it has acquired the remaining 60% stake:

WHIPPANY, N.J., June 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) is pleased to report that on Wednesday, June 3, 2015,  Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo. >>FULL PR

The MaryJane Group, Inc. MJMJ

MJMJ was among several stocks we tagged for potential upcoming bottom-plays at the end of last week, and while it did take the call an extra session to materialize, it did end up making that rebound yesterday.

The stock traded in a range from .0027-.0038; which marks an intraday swing of 41% on more than twice the average monthly volume. We’ll continue to monitor activity in the stock as the week progresses.

Under Armour, Inc. UA – Options

Yesterday morning, we updated readers as to the performance of the 07/31 $84 Calls that we initially alerted on Friday. From our observed low of 2.76, these contracts pushed further upward yesterday, extending to a new high of 4.20.

That pushes the overall range we’ve witnessed in just a two-session span to a respectable 52% We’ll continue to stay attuned to the activity as long as UA continues to perform well.

Extended Watchlist:
CPXX, NSPR, MEET, GBSN,